A Phase 1 Study of JNJ-87801493 in Combination with CD3 T-Cell Engagers

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505165-93-00

Acronym

87801493LYM1001

Enrollment

Registered

2024-02-19

Start date

2024-03-01

Completion date

Unknown

Last updated

2025-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Hodgkin Lymphoid Malignancies

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark, France, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026